Juvenile cancer: Improving care for adolescents and young adults within the frame of medical oncology
dc.contributor.author | Pentheroudakis, George | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.creator | Pentheroudakis, George | en |
dc.creator | Pavlidis, Nicholas | en |
dc.date.accessioned | 2018-06-22T09:54:26Z | |
dc.date.available | 2018-06-22T09:54:26Z | |
dc.date.issued | 2005 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42355 | |
dc.description.abstract | Despite unique tumour epidemiology, a higher cancer incidence and modest survival improvement compared to paediatric patients, adolescents and young adults aged 15-30 have not been considered as a separate, 'special' group of patients in the frame of medical oncology. In an effort to emphasise this need, we review the particular characteristics of diagnosed tumours, a aetiologic associations, nosologic classification, management, outcome and late toxic effects. Adolescents and young adults are in need of specialised care for intensive treatment of curable malignancies, skilled nursing care, interaction with peers, family and physicians as well as continuous psychosocial support. Enrolment in clinical research trials and close follow-up via the development of a cooperative infrastructure are imperative for the optimisation of management and avoidance of late effects. Similar to geriatric and paediatric oncology, we call for the intensification of treatment, support and research multidisciplinary efforts in order to better fulfil the pressing demands of this patient group. © 2005 European Society for Medical Oncology. | en |
dc.language.iso | eng | en |
dc.source | Annals of Oncology | en |
dc.subject | Age | en |
dc.subject | Age factors | en |
dc.subject | Adult | en |
dc.subject | Female | en |
dc.subject | Male | en |
dc.subject | Antineoplastic agent | en |
dc.subject | Bleomycin | en |
dc.subject | Chlormethine | en |
dc.subject | Cyclophosphamide | en |
dc.subject | Cytarabine | en |
dc.subject | Doxorubicin | en |
dc.subject | Human | en |
dc.subject | Methotrexate | en |
dc.subject | Neoplasms | en |
dc.subject | Prednisone | en |
dc.subject | Procarbazine | en |
dc.subject | Humans | en |
dc.subject | Doctor patient relation | en |
dc.subject | Cancer survival | en |
dc.subject | Follow up | en |
dc.subject | Priority journal | en |
dc.subject | Alopecia | en |
dc.subject | Clinical trial | en |
dc.subject | Drug efficacy | en |
dc.subject | Neurotoxicity | en |
dc.subject | Prognosis | en |
dc.subject | Drug tolerability | en |
dc.subject | Liver toxicity | en |
dc.subject | Treatment outcome | en |
dc.subject | Cancer research | en |
dc.subject | Review | en |
dc.subject | Cancer surgery | en |
dc.subject | Cancer mortality | en |
dc.subject | Survival | en |
dc.subject | Busulfan | en |
dc.subject | Cancer radiotherapy | en |
dc.subject | Dose response | en |
dc.subject | Melanoma | en |
dc.subject | Solid tumor | en |
dc.subject | Family | en |
dc.subject | Intestine obstruction | en |
dc.subject | Cancer risk | en |
dc.subject | Cancer adjuvant therapy | en |
dc.subject | Drug megadose | en |
dc.subject | Cancer incidence | en |
dc.subject | Carcinogenesis | en |
dc.subject | Cancer | en |
dc.subject | Incidence | en |
dc.subject | Treatment | en |
dc.subject | Alkylating agent | en |
dc.subject | Ifosfamide | en |
dc.subject | Intestinal fibrosis | en |
dc.subject | Xerostomia | en |
dc.subject | Quality of life | en |
dc.subject | Peripheral neuropathy | en |
dc.subject | Lung toxicity | en |
dc.subject | Lung fibrosis | en |
dc.subject | Nitrosourea derivative | en |
dc.subject | Cancer classification | en |
dc.subject | Social support | en |
dc.subject | Patient care planning | en |
dc.subject | Multimodality cancer therapy | en |
dc.subject | Germ cell tumor | en |
dc.subject | Adolescent | en |
dc.subject | Lymphoma | en |
dc.subject | Vincristine sulfate | en |
dc.subject | Second cancer | en |
dc.subject | Diethylstilbestrol | en |
dc.subject | Anthracycline | en |
dc.subject | Quality of health care | en |
dc.subject | Heredity | en |
dc.subject | Social interaction | en |
dc.subject | Brain radiation | en |
dc.subject | Adolescents | en |
dc.subject | Cognitive defect | en |
dc.subject | Weight gain | en |
dc.subject | Cooperation | en |
dc.subject | Environmental factor | en |
dc.subject | Medical oncology | en |
dc.subject | Infertility | en |
dc.subject | Leukemia | en |
dc.subject | Race difference | en |
dc.subject | Leukoencephalopathy | en |
dc.subject | Central nervous system tumor | en |
dc.subject | Raynaud phenomenon | en |
dc.subject | Soft tissue sarcoma | en |
dc.subject | Femur head necrosis | en |
dc.subject | Young adults | en |
dc.subject | Neuropathic pain | en |
dc.subject | Acne | en |
dc.subject | Aflatoxin | en |
dc.subject | Body weight disorder | en |
dc.subject | Bone tumor | en |
dc.subject | Brain atrophy | en |
dc.subject | Carcinogen | en |
dc.subject | Contraceptive agent | en |
dc.subject | Demyelination | en |
dc.subject | Heart injury | en |
dc.subject | Intensive care | en |
dc.subject | Interprofessional relations | en |
dc.subject | Lung injury | en |
dc.subject | Nursing | en |
dc.subject | Ototoxicity | en |
dc.subject | Skin carcinoma | en |
dc.subject | Surgical injury | en |
dc.subject | Tooth disease | en |
dc.title | Juvenile cancer: Improving care for adolescents and young adults within the frame of medical oncology | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1093/annonc/mdi036 | |
dc.description.volume | 16 | |
dc.description.issue | 2 | |
dc.description.startingpage | 181 | |
dc.description.endingpage | 188 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.contributor.orcid | Pentheroudakis, George [0000-0002-6632-2462] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |
dc.gnosis.orcid | 0000-0002-6632-2462 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |